ScholarIQanswers from OpenAlex & ORCID
Jennifer K. Litton
ResearcherPublications, citations & collaboration network
Jennifer K. Litton is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jennifer K. Litton have?
ScholarIQindexed works
Jennifer K. Litton has 565 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jennifer K. Litton have?
ScholarIQcitation count
Jennifer K. Litton has 23,069 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jennifer K. Litton?
ScholarIQh-index
Jennifer K. Litton has an h-index of 68 in OpenAlex.
What is the i10-index of Jennifer K. Litton?
ScholarIQi10-index
Jennifer K. Litton has an i10-index of 183 in OpenAlex.
What is the ORCID of Jennifer K. Litton?
ScholarIQorcid
The ORCID for Jennifer K. Litton is on the source record.
What is the OpenAlex record for Jennifer K. Litton?
ScholarIQopenalex
The OpenAlex for Jennifer K. Litton is on the source record.
What are the most-cited papers on Jennifer K. Litton?
ScholarIQmost cited works
Talazoparib in Patients with Advanced Breast Cancer and a Germline <i>BRCA</i> Mutation
Jennifer K. Litton, Hope S. Rugo, Johannes Ettl, Sara A. Hurvitz, Anthony Gonçalvès, Kyung-Hun Lee, Louis Fehrenbacher, Rinat Yerushalmi, Lida A. Mina, Miguel Martín, Henri Roché, Young‐Hyuck Im, Ruben G.W. Quek, Denka Markova, Iulia Cristina Tudor, Alison L. Hannah, W. Eiermann, Joanne L. Blum
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Mary B. Daly, Tuya Pal, Michael P. Berry, Saundra S. Buys, Patricia Dickson, Susan M. Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L. Hutton, CGC, Beth Y. Karlan, Seema Khan, Catherine Klein, Wendy Kohlmann, CGC, Allison W. Kurian, Christine Laronga, Jennifer K. Litton, Julie Mak, LCGC, Carolyn S. Menendez, Sofía D. Merajver, Barbara S. Norquist, Kenneth Offit, Holly J. Pederson, Gwen Reiser, CGC, Leigha Senter-Jamieson, CGC, Kristen M. Shannon, Rebecca Shatsky, Kala Visvanathan, Jeffrey N. Weitzel, Myra Wick, Kari B. Wisinski, Matthew B. Yurgelun, Susan Darlow, Mary A. Dwyer
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
Jong‐Ho Cha, Wenhao Yang, Weiya Xia, Yongkun Wei, Li-Chuan Chan, Seung‐Oe Lim, Chia-Wei Li, Tae‐Wan Kim, Shih-Shin Chang, Heng‐Huan Lee, Jennifer L. Hsu, Hung-Ling Wang, Chu‐Wei Kuo, Wei‐Chao Chang, Sirwan Hadad, Colin A. Purdie, Aaron McCoy, Shirong Cai, Yizheng Tu, Jennifer K. Litton, Elizabeth A. Mittendorf, Stacy Moulder, W. Fraser Symmans, Alastair M. Thompson, Helen Piwnica‐Worms, Chung‐Hsuan Chen, Kay‐Hooi Khoo, Mien‐Chie Hung
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
Mary B. Daly, Robert Pilarski, Michael P. Berry, Saundra S. Buys, Meagan Farmer, Susan Friedman, Judy E. Garber, Noah D. Kauff, Seema Khan, Catherine Klein, Wendy Kohlmann, Allison W. Kurian, Jennifer K. Litton, Lisa Madlensky, Sofía D. Merajver, Kenneth Offit, Tuya Pal, Gwen Reiser, Kristen M. Shannon, Elizabeth M. Swisher, Shaveta Vinayak, Nicoleta Voian, Jeffrey N. Weitzel, Myra Wick, Georgia L. Wiesner, Mary A. Dwyer, Susan Darlow
Genetic/Familial High-Risk Assessment: Breast and Ovarian
Mary B. Daly, Jennifer E. Axilbund, Saundra S. Buys, Beth Crawford, Carolyn Farrell, Susan Friedman, Judy E. Garber, Salil Goorha, Stephen B. Gruber, Heather Hampel, Virginia Kaklamani, Wendy Kohlmann, Allison W. Kurian, Jennifer K. Litton, P. Kelly Marcom, Robert L. Nussbaum, Kenneth Offit, Tuya Pal, Boris Pasche, Robert Pilarski, Gwen Reiser, Kristen M. Shannon, Jeffrey R. Smith, Elizabeth M. Swisher, Jeffrey N. Weitzel